Biodexa Pharmaceuticals Plc carries a market capitalization of 1.32M, placing it among publicly traded companies globally.
| Market Cap | 1.32M |
| Enterprise Value | N/A |
Biodexa Pharmaceuticals Plc's stock has declined approximately -95.83529% over the past 52 weeks. The 50-day moving average sits at 3.06, while the 200-day moving average is 12.46.
| Beta (5Y) | N/A |
| 52-Week Price Change | -95.83529% |
| 50-Day Moving Average | 3.06 |
| 200-Day Moving Average | 12.46 |
| Average Volume (20 Days) | N/A |
Biodexa Pharmaceuticals Plc's most recent stock split took place on April 6, 2026 with a 5:1 split ratio.
| Last Split Date | 4/6/2026 |
| Split Ratio | 5:1 |